Interacting Drugs |
Meningococcal serogroup C conjugate vaccine vs Belimumab |
Security Level |
 |
Mechanism |
Belimumab: May diminish the therapeutic effect of Vaccines (Inactivated). |
Management |
Consider therapy modification |
Meningococcal serogroup C conjugate vaccine vs Belimumab
Post Review about Meningococcal serogroup C conjugate vaccine vs Belimumab Click here to cancel reply.
Other Interactions of Meningococcal serogroup C conjugate vaccine
Other Interactions of Belimumab
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.